Nephros (NEPH) Other financing activities (2011 - 2026)

Nephros' (NEPH) quarterly Other financing activities came in at $290000.0 in Q1 2026, up 1260.0% quarter-over-quarter from -$25000.0 in Q3 2022.

Nephros (NEPH) Other financing activities (2011 - 2026) Analysis & Trends

Nephros' Other financing activities history runs 11 years deep, the most recent figure standing at $290000.0 for Q1 2026.

On a quarterly basis, Other financing activities changed N/A year-over-year to $290000.0 in Q1 2026; TTM through Mar 2026 was $265000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $163000.0, down 20.1% from the prior year.
Other financing activities climbed to $290000.0 in Q1 2026 per NEPH's latest filing, from -$25000.0 in the prior quarter.
Across five years, Other financing activities topped out at $290000.0 in Q1 2026 and bottomed at -$25000.0 in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn
10	Nephros	40.88 Mn	36.86 Mn	2.99 Mn

Download Data